Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Molecular Partners Ag (MOLN) Payables: 2020-2024

Historic Payables for Molecular Partners Ag (MOLN) over the last 5 years, with Dec 2024 value amounting to $2.1 million.

  • Molecular Partners Ag's Payables rose 41.74% to $2.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was $13.9 million, marking a year-over-year decrease of 23.77%. This contributed to the annual value of $2.1 million for FY2024, which is 42.91% up from last year.
  • Per Molecular Partners Ag's latest filing, its Payables stood at $2.1 million for FY2024, which was up 42.91% from $1.5 million recorded in FY2023.
  • In the past 5 years, Molecular Partners Ag's Payables registered a high of $8.0 million during FY2021, and its lowest value of $1.5 million during FY2023.
  • Moreover, its 3-year median value for Payables was $2.1 million (2024), whereas its average is $1.9 million.
  • In the last 5 years, Molecular Partners Ag's Payables crashed by 72.24% in 2022 and then spiked by 42.91% in 2024.
  • Over the past 5 years, Molecular Partners Ag's Payables (Yearly) stood at $6.4 million in 2020, then grew by 24.37% to $8.0 million in 2021, then crashed by 72.24% to $2.2 million in 2022, then crashed by 33.53% to $1.5 million in 2023, then surged by 42.91% to $2.1 million in 2024.